Ali Faraz 4
4 · Tenaya Therapeutics, Inc. · Filed Aug 18, 2025
Insider Transaction Report
Form 4
Ali Faraz
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-18$1.25/sh−5,720$7,167→ 311,605 total - Sale
Common Stock
2025-08-18$1.25/sh−4,920$6,165→ 302,792 total - Sale
Common Stock
2025-08-18$1.25/sh−3,893$4,878→ 307,712 total
Footnotes (7)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 243,943 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- [F5]Includes 233,318 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F6]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
- [F7]Includes 219,881 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.